GlassScriptPhysician profile
Carl James Spivak
NPI 1316042989
$7,462.42
in general payments reported to CMS, 2019-2025
13 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,011 · 2020: $70.43 · 2021: $78.46 · 2022: $591 · 2023: $111 · 2024: $449 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Joimax, INC. | $5,699.53 | 2019 | |
| Integrity Implants INC. | $520.22 | 2022 | |
| Abbott Laboratories | $391.84 | 2021-2025 | Eterna, Proclaim |
| Si-Bone, INC. | $225.10 | 2019-2020 | |
| Foundation Fusion Solutions, LLC | $181.92 | 2024 | |
| Nevro Corp. | $117.26 | 2024 | Senza |
| Medtronic USA, INC. | $114.44 | 2019 | |
| Curonix LLC | $74.21 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Elements, INC. | $51.54 | 2024 | |
| Terumo Bct, INC. | $29.56 | 2020 | |
| Guard Medical INC. | $23.77 | 2024 | Npseal Large |
| Globus Medical, INC. | $20.11 | 2025 | Vyrsa V1 |
| Boston Scientific Corporation | $12.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Spivak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.